ID   NCC-GCTB15-C1
AC   CVCL_E6MQ
RX   PubMed=39604602;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 38 hours (PubMed=39604602).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=39604602).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=39604602
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D21S11: 29,31.2
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=39604602; DOI=10.1007/s13577-024-01150-2;
RA   Iwata S., Ono T., Noguchi R., Osaki J., Adachi Y., Shiota Y., Iwata S.,
RA   Nishino S., Yoshida A., Ohtori S., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-GCTB14-C1 and
RT   NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell
RT   tumor of bone.";
RL   Hum. Cell 38:20.1-20.8(2025).
//